Management of patients with type 2 diabetes with once-weekly semaglutide versus dulaglutide, exenatide ER, liraglutide and lixisenatide: a cost-effectiveness analysis in the Danish setting
The primary concerns with using discoloured tirzepatide include: Loss of therapeutic effect : Degradation of the active peptide may render the medication ineffective, leading to inadequate glycaemic control or failure to achieve intended weight management outcomes Potential toxicity : Degradation products or contaminants responsible for the colour change may pose direct health risks Immunogenicity : Altered protein structures can potentially trigger unwanted immune responses Infection risk : If discolouration results from contamination, injection could introduce harmful substances into subcutaneous tissue If you discover discoloured tirzepatide, you should: If you have inadvertently used discoloured tirzepatide and experience symptoms of a severe allergic reaction (such as difficulty breathing, swelling of face/throat, or severe rash), call 999 or go to A&E immediately
Some prescription pain medicines, such as opioids, may cause constipation
Claimants seek compensation for Ozempic-related injuries, drawing attention to the lack of transparency and prioritization of drug safety in the pharmaceutical industry
Efficacy and safety of semaglutide for weight management: evidence from the STEP program
